Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy
European Journal of Neurology · 2024-08 · 31 (8)
DOI: 10.1111/ene.16320 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 30.04.2024. Verfasst von Negin Badihian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive, Diffusion Tensor Imaging, Positron-Emission Tomography. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background and purpose Primary lateral sclerosis (PLS) is a neurodegenerative disorder that primarily affects the central motor system. In rare cases, clinical features of PLS may overlap with those of progressive supranuclear palsy (PSP). We investigate neuroimaging features that can help distinguish PLS with overlapping features of PSP (PLS‐PSP) from PSP.
Methods
Six patients with PLS‐PSP were enrolled between 2019 and 2023. We compared their clinical and neuroimaging characteristics with 18 PSP–Richardson syndrome (PSP‐RS) patients and 20 healthy controls. Magnetic resonance imaging, 18 F‐flortaucipir positron emission tomography (PET), quantitative susceptibility mapping, and diffusion tensor imaging tractography (DTI) were performed to evaluate eight brain regions of interest. Area under the receiver operating characteristic curve (AUROC) was calculated.
Results
Five of the six PLS‐PSP patients (83.3%) were male. Median age at symptom onset was 61.5 (52.5–63) years, and all had mixed features of PLS and PSP. Volumes of the pallidum, caudate, midbrain, and cerebellar dentate were smaller in PSP‐RS than PLS‐PSP, providing good discrimination (AUROC = 0.75 for all). The susceptibilities in pallidum, midbrain, and cerebellar dentate were greater in PSP‐RS compared to PLS‐PSP, providing excellent discrimination (AUROC ≥ 0.90 for all). On DTI, fractional anisotropy (FA) in the posterior limb of the internal capsule from the corticospinal tract was lower in PLS‐PSP compared to PSP‐RS (AUROC = 0.86), but FA in the superior cerebellar peduncle was lower in PSP‐RS (AUROC = 0.95). Pallidum flortaucipir PET uptake was greater in PSP‐RS compared to PLS‐PSP (AUROC = 0.74).
Conclusions
Regional brain volume, tractography, and magnetic susceptibility, but not tau‐PET, are useful in distinguishing PLS‐PSP from PSP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Negin Badihian, Rodolfo G Gatto, Heather M Clark, Keith A Josephs
Förderung
- NINDS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Badihian, N., Gatto, R. G., Satoh, R., Ali, F., Clark, H. M., Pham, N. T. T., Whitwell, J. L., & Josephs, K. A. (2024). Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy. European Journal of Neurology, 31(8). https://doi.org/10.1111/ene.16320
Vancouver
Badihian N, Gatto RG, Satoh R, Ali F, Clark HM, Pham NTT, et al. Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy. European Journal of Neurology. 2024;31(8). doi:10.1111/ene.16320
BibTeX
@article{Badihian2024,
author = {Badihian, Negin and Gatto, Rodolfo G and Satoh, Ryota and Ali, Farwa and Clark, Heather M and Pham, Nha Trang Thu and Whitwell, Jennifer L and Josephs, Keith A},
title = {Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy},
journal = {European Journal of Neurology},
year = {2024},
volume = {31},
number = {8},
doi = {10.1111/ene.16320}
}
EUVIMED